Retail Pharmacy Services

Retail Pharmacy Services

Imperial College Healthcare Outpatient Dispensing, Homecare and Retail Pharmacy Services.

UK-Birmingham: pharmacy services

2012/S 111-184646

Contract notice

Services

Directive 2004/18/EC

Section I: Contracting authority

I.1)Name, addresses and contact point(s)

Imperial College Healthcare NHS Trust (HealthTrust Europe LLP acting as an agent)
1 Hagley Road, Edgbaston
For the attention of: Sanjeev Narwal
B16 8TG Birmingham
UNITED KINGDOM
Telephone: +44 7908115360
E-mail: sanjeev.narwal@healthtrusteurope.com
Fax: +44 1216871345

Internet address(es):

General address of the contracting authority: https://healthtrusteurope.bravosolution.co.uk

Further information can be obtained from: The above mentioned contact point(s)

Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)

Tenders or requests to participate must be sent to: The above mentioned contact point(s)

I.2)Type of the contracting authority

Body governed by public law
I.3)Main activity

Health
Other: Please refer to Section II.1.5
I.4)Contract award on behalf of other contracting authorities

The contracting authority is purchasing on behalf of other contracting authorities: yes

Section II: Object of the contract

II.1)Description
II.1.1)Title attributed to the contract by the contracting authority:

Imperial College Healthcare Outpatient Dispensing, Homecare & Retail Pharmacy Services.
II.1.2)Type of contract and location of works, place of delivery or of performance

Services
Service category No 25: Health and social services
Main site or location of works, place of delivery or of performance: London North West – Imperial College Healthcare NHS Trust and the Trust reserves the right to increase the number of hospitals, specifically those within London or within its alliances and partnerships, to which the provider will provide its pharmacy outpatient dispensing services and its homecare and retail pharmacy services to, at any time during at any time during the competitive dialogue process or contract period.
NUTS code UKI
II.1.3)Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)

The notice involves a public contract
II.1.4)Information on framework agreement
II.1.5)Short description of the contract or purchase(s)

Imperial College Healthcare NHS Trust (the Trust) is seizing the opportunity to modernise its pharmacy services provision by appointing a community pharmacy provider with a key aim of improving patient experience. It is envisaged that the procurement will comprise of the following three core elements:
Pharmacy outpatient dispensing services – this is likely to constitute the main focus of the procurement. The provider will need to establish, as a minimum, a registered pharmacy presence at Hammersmith Hospital, Charing Cross Hospital and St Mary’s Hospital. The provider will also be required to provide outpatient services to the Western Eye Hospital and Queen Charlotte’s and Chelsea Hospital. The Trust estimates that current volumes of outpatient transactions amount to approximately 300 000 per annum with current spending on outpatient medicines amounting to approximately 25 000 000 GBP. These figures are estimates only and do not provide any guarantees of future volumes or spending. The provider will be expected to dispense medicines in accordance with local treatment guidelines and protocols. The outpatient model should also incorporate a service that enables the dispensing of medicines for GP-led services;
Homecare pharmacy services – the Trust is interested in exploring with bidders options for the management and delivery of homecare pharmacy services and the potential development of an integrated service model. At present, the Trust estimates that it has approximately 5 500 patients receiving home healthcare pharmacy services across a number of clinical specialities including rheumatology, HIV and renal. The Trust estimates that current spending on home delivered medicines amounts to approximately 30 000 000 GBP. Again, these figures are provided for information purposes only and are not guarantees as to future volumes or spending.
Retail pharmacy services – the delivery of retail pharmacy services to include but is not necessarily limited to, outlets on the Hammersmith Hospital, Charing Cross Hospital and St Mary’s Hospital sites. The Trust anticipates exploring retail opportunities at these sites with bidders during the procurement process.
In addition, the Trust is keen to explore proposals from bidders for further development opportunities that may include, but are not necessarily limited to, day case and discharge prescriptions, improving patient pathways into primary care and public health benefits and other similar services.
The Trust is a leading provider of a broad range of clinical services to the local community. It also provides services on a wider scale (for example, it provides the largest facility in Europe for nephrology, dialysis and transplantation). The main objective of the Trust is to improve the health of the communities it serves through world-class medical research, education and patient care. The Trust is seeking a provider who is willing to work with the Trust to deliver on this objective.
The above information summarises the Trust’s current understanding of its requirements but the precise scope of the contract will be determined during dialogue with shortlisted bidders, depending on the solutions that are put forward and other factors that may affect the Trust’s requirements. The scope of this procurement relates to the provision of services to all patients of the Trust and may be subject to change as a result of future organisational and/or site developments.
Clinical trial medicines and other medicines provided as part of a clinical trial protocol may be out of scope.
As the contract for this procurement falls within Part B of Schedule 3 to the Public Contracts Regulations 2006, the Trust is not obliged to follow one of the prescriptive procedures set out in those Regulations. However, the Trust intends to use the competitive dialogue procedure as a model for this procurement without being bound by the rules that usually attach to that procedure. The Trust therefore reserves the right to deviate from the competitive dialogue procedure at any stage. Any changes to the process will be communicated to all bidders in advance in accordance with the principles of equal treatment, transparency and non-discrimination.
The contract length is expected to be up to 120 months (from the award of the contract) with the option to extend up to 180 months.
The Trust reserves the right to increase the number of hospitals, specifically those within London or within its alliances and partnerships, to which the provider will provide its pharmacy outpatient dispensing services and its homecare and retail pharmacy services to, at any time during the competitive dialogue process or contract period.
An overview of the short-listing criteria is set out in more detail in the Pre-qualification questionnaire (PQQ) which will be made available alongside the OJEU advert.
II.1.6)Common procurement vocabulary (CPV)

85149000

II.1.7)Information about Government Procurement Agreement (GPA)

The contract is covered by the Government Procurement Agreement (GPA): yes
II.1.8)Lots

This contract is divided into lots: no
II.1.9)Information about variants

Variants will be accepted: yes
II.2)Quantity or scope of the contract
II.2.1)Total quantity or scope:

Pharmacy outpatient dispensing services – this is likely to constitute the main focus of the procurement. The Trust estimates that current volumes of outpatient transactions amount to approximately 300 000 per annum with current spending on outpatient medicines amounting to approximately 25 000 000 GBP. These figures are estimates only and do not provide any guarantees of future volumes or spending. The outpatient model should also incorporate a service that enables the dispensing of medicines for GP-led services;
Homecare pharmacy services – at present, the Trust estimates that it has approximately 5 500 patients receiving home healthcare pharmacy services across a number of clinical specialities including rheumatology, HIV and renal. The Trust estimates that current spending on home delivered medicines amounts to approximately 30 000 000 GBP. Again, these figures are provided for information purposes only and are not guarantees as to future volumes or spending.
Retail pharmacy services – the delivery of retail pharmacy services to include but is not necessarily limited to, outlets on the Hammersmith Hospital, Charing Cross Hospital and St Mary’s Hospital sites. The Trust anticipates exploring retail opportunities at these sites with bidders during the procurement process.
In addition, the Trust is keen to explore proposals from bidders for further development opportunities that may include, but are not necessarily limited to, day case and discharge prescriptions, improving patient pathways into primary care and public health benefits and other similar services.
The above information summarises the Trust’s current understanding of its requirements but the precise scope of the contract will be determined during dialogue with shortlisted bidders, depending on the solutions that are put forward and other factors that may affect the Trust’s requirements. The scope of this procurement relates to the provision of services to all patients of the Trust and may be subject to change as a result of future organisational and/or site developments.
Clinical trial medicines and other medicines provided as part of a clinical trial protocol may be out of scope.
II.2.2)Information about options
II.2.3)Information about renewals
II.3)Duration of the contract or time limit for completion

Duration in months: 120 (from the award of the contract)

Section III: Legal, economic, financial and technical information

III.1)Conditions relating to the contract
III.1.1)Deposits and guarantees required:

Parent company or other guarantees may be required in certain circumstances. See the invitation to competitive dialogue (ICD) documents for further details.
III.1.2)Main financing conditions and payment arrangements and/or reference to the relevant provisions governing them:
III.1.3)Legal form to be taken by the group of economic operators to whom the contract is to be awarded:

Requests to participate will be accepted from groupings of economic operators (consortia). In the event of a successful consortium bid, the Trust may specify that the consortium member takes a particular legal form and/or require that a single consortium member takes primary liability or that each member undertakes joint and several liability irrespective of the legal form adopted. Where a subsidiary company is used, the ultimate parent company may be required to provide a guarantee in respect of the performance of the contract by the subsidiary before acceptance.
III.1.4)Other particular conditions

The performance of the contract is subject to particular conditions: yes
Description of particular conditions: Particular conditions to which the performance of the contract is subject may be set out in the Invitation to Competitive Dialogue.
III.2)Conditions for participation
III.2.1)Personal situation of economic operators, including requirements relating to enrolment on professional or trade registers

Information and formalities necessary for evaluating if the requirements are met: Any supplier may be disqualified who:
(a) is bankrupt or is being wound up, where his affairs are being administered by the court, where he has entered into an arrangement with creditors, where he has suspended business activities or is in any analogous situation arising from a similar procedure under national laws and regulations;
(b) is the subject of proceedings for a declaration of bankruptcy, for an order for compulsory winding up or administration by the court or of an arrangement with creditors or of any other similar proceedings under national laws and regulations;
(c) has been convicted by a judgment which has the force of res judicata in accordance with the legal provisions of the country of any offence concerning his professional conduct;
(d) has been guilty of grave professional misconduct proven by any means which the contracting authorities can demonstrate;
(e) has not fulfilled obligations relating to the payment of social security contributions in accordance with the legal provisions of the country in which he is established or with those of the country of the contracting authority;
(f) has not fulfilled obligations relating to the payment of taxes in accordance with the legal provisions of the country in which he is established or with those of the country of the contracting authority;
(g) is guilty of serious misrepresentation in supplying the information required under this Section or has not supplied such information;
(h) has been the subject of a conviction for participation in a criminal organisation, as defined in Article 2(1) of Council Joint Action 98/733/JHA;
(i) has been the subject of a conviction for corruption, as defined in Article 3 of the Council Act of 26.5.1972 and Article 3(1) of Council Joint Action 98/742/JHA3 respectively;
(j) has been the subject of a conviction for fraud within the meaning of Article 1 of the Convention relating to the protection of the financial interests of the European Communities;
(k) has been the subject of a conviction for money laundering, as defined in Article 1 of Council Directive 91/308/EEC of 10.6.1991 on prevention of the use of the financial system for the purpose of money laundering.
Information and formalities necessary for evaluating if requirements are met (If applicable):
1) Entering general PQQ supplier information. HeathTrust Europe utilizes the NHS Supplier Information Database (sid4health) to manage and assess general pre-qualification information in the form of a profile. Candidates are requested to provide their profile in sid4health as follows:
i) Candidates should register on sid4health at http://www.sid4health.nhs.uk/home.actionand submit their sid4health company profile for publication to the system. Candidates already registered on sid4health must ensure that information is up to date.ii) Candidates should ensure all the relevant sections of their sid4health profile are completed to demonstrate their ability to meet the short-listing criteria applicable to this contract.
iii) Where access to sid4health is unavailable, please contact the sid4health Helpdesk at: help@sid4health.nhs.uk.
III.2.2)Economic and financial ability

Information and formalities necessary for evaluating if the requirements are met: (a) appropriate statements from banks or, where appropriate, evidence of relevant professional risk indemnity insurance;
(b) the presentation of balance-sheets or extracts from the balance-sheets, where publication of the balance-sheet is required under the law of the country in which the economic operator is established;
(c) a statement of the undertaking’s overall turnover and, where appropriate, of turnover in the area covered by the contract for a maximum of the last three financial years available, depending on the date on which the undertaking was set up or the economic operator started trading, as far as the information on these turnovers is available.
Minimum level(s) of standards possibly required: Average turnover for the past 3 years is 3 times greater than the average annual estimated contract value.
III.2.3)Technical capacity

Information and formalities necessary for evaluating if the requirements are met:
As per requirements to complete sid4health profile – see III.2.1 for more information on how to complete sid4health profile.
III.2.4)Information about reserved contracts
III.3)Conditions specific to services contracts
III.3.1)Information about a particular profession

Execution of the service is reserved to a particular profession: yes
Reference to the relevant law, regulation or administrative provision:
III.3.2)Staff responsible for the execution of the service

Legal persons should indicate the names and professional qualifications of the staff responsible for the execution of the service: no

Section IV: Procedure

IV.1)Type of procedure
IV.1.1)Type of procedure

competitive dialogue
IV.1.2)Limitations on the number of operators who will be invited to tender or to participate

Envisaged minimum number 3: and maximum number 5
Objective criteria for choosing the limited number of candidates: Please refer to the PQQ for more details about this requirement and shortlisting criteria. The Trust reserves the right to vary the minimum and maximum number of suppliers taken to the ICD.
IV.1.3)Reduction of the number of operators during the negotiation or dialogue

Recourse to staged procedure to gradually reduce the number of solutions to be discussed or tenders to be negotiated yes
IV.2)Award criteria
IV.2.1)Award criteria

The most economically advantageous tender in terms of the criteria stated in the specifications, in the invitation to tender or to negotiate or in the descriptive document
IV.2.2)Information about electronic auction

An electronic auction will be used: no
IV.3)Administrative information
IV.3.1)File reference number attributed by the contracting authority:

GPJ-001563
IV.3.2)Previous publication(s) concerning the same contract

no
IV.3.3)Conditions for obtaining specifications and additional documents or descriptive document

Time limit for receipt of requests for documents or for accessing documents: 6.7.2012 – 12:00
Payable documents: no
IV.3.4)Time limit for receipt of tenders or requests to participate

9.7.2012 – 12:00
IV.3.5)Date of dispatch of invitations to tender or to participate to selected candidates
IV.3.6)Language(s) in which tenders or requests to participate may be drawn up

English.
IV.3.7)Minimum time frame during which the tenderer must maintain the tender
IV.3.8)Conditions for opening tenders

Section VI: Complementary information

VI.1)Information about recurrence

This is a recurrent procurement: no
VI.2)Information about European Union funds

The contract is related to a project and/or programme financed by European Union funds: no
VI.3)Additional information

The contract as defined in this notice will be entered into by Imperial College Healthcare NHS Trust. HTE has been appointed by Imperial College Healthcare NHS Trust as its agent to carry out certain procurement functions in relation to this contract. The contract conditions will be set out in the ICD. It is the intention to include certain contractual provisions regarding an Activity Based Income Charge, payable by the supplier(s) to HTE management charge, which may be applied to purchases made under the contract awarded. Further details will be made available via the contract documentation and information released during the course of the tender process. If and when this requirement is offered to tender, this may be done in whole or in part via electronic means using the Internet and may be through the medium of an electronic reverse auction. Submission of expressions of interest and procurement specific information: This exercise will be conducted on the HTE portal. Candidates wishing to be considered must register their expression of interest as follows: Register on the HTE portal at https://healthtrusteurope.bravosolution.co.uk. Login to the portal with the username/password. Click the PQQs/ITTs Open to All Suppliers link. These are the PQQs/ITTs open to any registered supplier. Click on the relevant PQQ/ ITT to access the content. Click the Express Interest button at the top of the page. This will move the PQQ/ITT into your My PQQs/My ITTS page. You can access any attachments by clicking Buyer Attachments (if required in III.2.1.1.ii) in the PQQ/ITT Details box. Follow the onscreen instructions to complete the PQQ/ITT. Submit your reply using the Submit Response button at the top of the page. If you require any further advice, contact the e-Tendering Help Desk.

The Trust may accept variant bids in addition to a standard bid as set out in the tender/contract documents provided the Trust’s core requirements are met and provided the variant is submitted in accordance with the tender/contract documents.
Candidates are advised that the Trust is subject to the Freedom of Information Act 2000 (the Act). If a candidate considers that any of the information supplied as part of this procurement procedure should not be disclosed because of its commercial sensitivity, confidentiality or otherwise, they must, when providing this information, clearly identify the specific information they do not wish to be disclosed and clearly specify the reasons for its sensitivity. The Trust shall take such statements into consideration in the event that it receives a request pursuant to the Act which relates to the information provided by the interested party. Please note, it is not sufficient to include a statement of confidentiality encompassing all the information provided in the response.
The Trust shall not be responsible for any costs, charges or expenses incurred by candidates or tenderers and accepts no liability for any costs, charges or expenses, irrespective of the outcome of the competition, or if the competition is cancelled or postponed.All dates and time periods specified in this notice are only provisional and the Trust reserves the right to change these.
The Trust reserves the right to not award any or part of this contract.
Tenders and all supporting documentation must be priced in sterling and all payments will be made in sterling.
Expressions of interest which are submitted without the information requested may not be considered.
Suppliers should register their suppliers profile on sid4health at www.sid4health.nhs.uk.

VI.4)Procedures for appeal
VI.4.1)Body responsible for appeal procedures
VI.4.2)Lodging of appeals
VI.4.3)Service from which information about the lodging of appeals may be obtained

VI.5)Date of dispatch of this notice:8.6.2012